// App-Quantinova.ai

Mo1550 : Sitagliptin for the Treatment of Non-Alcoholic Steatohepatitis in Patients With Type 2 Diabetes

Researchers

Presenter

  • Tisha R. Joy

Principal Investigators

  • Charles McKenzie

  • Melanie Beaton

Medical Centers

  • Gastroenterology, Western University, London, Ontario, Canada

  • Gastroenterology, Western University, London, Ontario, Canada

  • Gastroenterology, Western University, London, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic fatty liver disease

  • Diabetes

  • Fatty Liver Disease

  • Type 2 diabetes mellitus

  • Hepatic fibrosis

  • Dyslipidemia

  • Obesity

  • Nonalcoholic steatohepatitis

Biomarkers

  • N/A

Drug/Treatment

  • Sitagliptin

Outcome

  • Unknown

Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved